Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Biglari A | BH-A | Sep 19, 2024 | 851.42 | 0.00 |
Biglari B | BH | Sep 19, 2024 | 177.63 | +1.93 |
Bilibili ADR | BILI | Sep 19, 2024 | 15.78 | +6.41 |
Bill.com | BILL | Sep 19, 2024 | 54.76 | +6.00 |
Binah Capital Group | BCG | Sep 19, 2024 | 3.00 | +5.63 |
BIO-key International | BKYI | Sep 19, 2024 | 1.08 | -10.74 |
Bio-Path | BPTH | Sep 19, 2024 | 0.96 | -3.93 |
Bio-Rad Laboratories A | BIO | Sep 19, 2024 | 344.60 | +1.22 |
Bio-Rad Laboratories B | BIO-B | Sep 19, 2024 | 326.74 | 0.00 |
Bio-Techne | TECH | Sep 19, 2024 | 80.36 | +5.03 |
BioAffinity Technologies | BIAF | Sep 19, 2024 | 2.01 | +10.44 |
BioAtla | BCAB | Sep 19, 2024 | 1.74 | +4.82 |
BioCardia | BCDA | Sep 19, 2024 | 2.98 | -3.25 |
Bioceres Crop Solutions | BIOX | Sep 19, 2024 | 8.55 | +1.42 |
BioCryst Pharmaceuticals | BCRX | Sep 19, 2024 | 8.15 | +2.39 |
Biodesix | BDSX | Sep 19, 2024 | 1.78 | +2.30 |
Biodexa Pharma ADR | BDRX | Sep 19, 2024 | 0.37 | -1.77 |
Biofrontera | BFRI | Sep 19, 2024 | 1.28 | -0.78 |
Biogen | BIIB | Sep 19, 2024 | 201.44 | +1.95 |
Biohaven | BHVN | Sep 19, 2024 | 40.42 | +2.59 |
Biolase | BIOL | Sep 19, 2024 | 0.13 | 0.00 |
BioLife Solutions | BLFS | Sep 19, 2024 | 25.72 | +8.43 |
BioLineRX ADR | BLRX | Sep 19, 2024 | 0.65 | +4.42 |
BioMarin Pharmaceutical | BMRN | Sep 19, 2024 | 71.41 | +0.38 |
Biomea Fusion | BMEA | Sep 19, 2024 | 8.71 | +0.23 |
Biomerica | BMRA | Sep 19, 2024 | 0.32 | +3.29 |
BiomX | PHGE | Sep 19, 2024 | 1.05 | +2.83 |
Bionano Genomics | BNGO | Sep 19, 2024 | 0.42 | +4.95 |
BioNexus Gene Lab | BGLC | Sep 19, 2024 | 0.41 | -0.98 |
Bionomics ADR | BNOX | Sep 19, 2024 | 0.63 | -1.84 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.